A critical advance in cancer investigation is emerging with the use of VHH fragments to re-engage mutated p53. This vital malignant protector protein is frequently lost in various forms of malignancies, causing https://bookmarkchamp.com/story21881996/nanobodies-reactivate-the-p53-protein-new-new-pathway-for-cancer-treatment